GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use

由 Vis, Roeland, Lavalaye, Jules, van de Garde, Ewoudt MW
發表在 EJNMMI Res (2015)

Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy

由 Bui, Tam Binh V, Burgers, Desirée MT, Agterof, Mariette J, van de Garde, Ewoudt MW
發表在 Breast Cancer (Auckl) (2019)

Validation of an automated method for compounding monoclonal antibody patient doses: Case studies of Avastin(®) (bevacizumab), Remicade(®) (infliximab) and Herceptin(®) (trastuzuma...

由 Peters, Bas J.M., Capelle, Martinus A.H., Arvinte, Tudor, van de Garde, Ewoudt M.W.
出版 2013

Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis

由 Spoorenberg, Simone MC, Bos, Willem Jan W, Heijligenberg, Rik, Voorn, Paul GP, Grutters, Jan C, Rijkers, Ger T, van de Garde, Ewoudt MW
出版 2014

Altered splenic [(89)Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism?

由 Adams, Human, Meek, Bob, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, Keijsers, Ruth G, Grutters, Jan C
發表在 Am J Nucl Med Mol Imaging (2020)

[(89)Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study

由 Adams, Human, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, van Dongen, Guus AMS, Grutters, Jan C, Keijsers, Ruth G
發表在 Am J Nucl Med Mol Imaging (2019)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study

由 van de Garde, Ewoudt MW, Endeman, Henrik, van Hemert, Remco N, Voorn, G Paul, Deneer, Vera HM, Leufkens, Hubert GM, van den Bosch, Jules MM, Biesma, Douwe H
出版 2007

Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer

由 Cramer-van der Welle, Christine M., Peters, Bas J.M., Schramel, Franz M.N.H., Klungel, Olaf H., Groen, Harry J.M., van de Garde, Ewoudt M.W.
發表在 Eur Respir J (2018)

Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative

由 Reesink, Daan J., van de Garde, Ewoudt M.W., Somford, Diederik M., Meijer, Richard P., Los, Maartje, Biesma, Douwe H., Horenblas, Simon, van Melick, Harm H.E., van der Nat, Paul B.
發表在 Eur Urol Open Sci (2021)

Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline

由 Sieswerda, Elske, de Boer, Mark G.J., Bonten, Marc M.J., Boersma, Wim G., Jonkers, René E., Aleva, Roel M., Kullberg, Bart-Jan, Schouten, Jeroen A., van de Garde, Ewoudt M.W., Verheij, Theo J., van der Eerden, Menno M., Prins, Jan M., Wiersinga, W. Joost
發表在 Clin Microbiol Infect (2021)